Does the 1:1:1 Transfusion Ratio Mortality Benefit Hold True in Ultra-massive Transfusion? A Study From the Product (Patient Related Outcomes During Ultra-massive transfusion multi-Center Trial) Consortium.
- Published in:
- American Surgeon, 2025, v. 91, n. 9, p. 1484, doi. 10.1177/00031348251358431
- By:
- Publication type:
- Article